| UniProt ID | CCNL1_HUMAN | |
|---|---|---|
| UniProt AC | Q9UK58 | |
| Protein Name | Cyclin-L1 | |
| Gene Name | CCNL1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 526 | |
| Subcellular Localization | Nucleus speckle . Nucleus, nucleoplasm . Found in nuclear intrachromatin granules clusters (IGC), also called nuclear speckles, which are storage compartments for nuclear proteins involved in mRNA processing.. | |
| Protein Description | Involved in pre-mRNA splicing. Functions in association with cyclin-dependent kinases (CDKs). [PubMed: 18216018 Inhibited by the CDK-specific inhibitor CDKN1A/p21] | |
| Protein Sequence | MASGPHSTATAAAAASSAAPSAGGSSSGTTTTTTTTTGGILIGDRLYSEVSLTIDHSLIPEERLSPTPSMQDGLDLPSETDLRILGCELIQAAGILLRLPQVAMATGQVLFHRFFYSKSFVKHSFEIVAMACINLASKIEEAPRRIRDVINVFHHLRQLRGKRTPSPLILDQNYINTKNQVIKAERRVLKELGFCVHVKHPHKIIVMYLQVLECERNQTLVQTAWNYMNDSLRTNVFVRFQPETIACACIYLAARALQIPLPTRPHWFLLFGTTEEEIQEICIETLRLYTRKKPNYELLEKEVEKRKVALQEAKLKAKGLNPDGTPALSTLGGFSPASKPSSPREVKAEEKSPISINVKTVKKEPEDRQQASKSPYNGVRKDSKRSRNSRSASRSRSRTRSRSRSHTPRRHYNNRRSRSGTYSSRSRSRSRSHSESPRRHHNHGSPHLKAKHTRDDLKSSNRHGHKRKKSRSRSQSKSRDHSDAAKKHRHERGHHRDRRERSRSFERSHKSKHHGGSRSGHGRHRR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 30 | Phosphorylation | GGSSSGTTTTTTTTT CCCCCCCEEEEEEEC | 26.18 | - | |
| 32 | Phosphorylation | SSSGTTTTTTTTTGG CCCCCEEEEEEECCC | 21.76 | - | |
| 33 | Phosphorylation | SSGTTTTTTTTTGGI CCCCEEEEEEECCCE | 21.76 | - | |
| 37 | Phosphorylation | TTTTTTTTGGILIGD EEEEEEECCCEEECC | 31.17 | - | |
| 47 | Phosphorylation | ILIGDRLYSEVSLTI EEECCCCEEEEEEEE | 12.04 | 28122231 | |
| 48 | Phosphorylation | LIGDRLYSEVSLTID EECCCCEEEEEEEEC | 35.79 | 28122231 | |
| 51 | Phosphorylation | DRLYSEVSLTIDHSL CCCEEEEEEEECCCC | 18.75 | 28122231 | |
| 53 | Phosphorylation | LYSEVSLTIDHSLIP CEEEEEEEECCCCCC | 19.49 | 28122231 | |
| 57 | Phosphorylation | VSLTIDHSLIPEERL EEEEECCCCCCHHHC | 25.01 | 28122231 | |
| 65 | Phosphorylation | LIPEERLSPTPSMQD CCCHHHCCCCCCCCC | 32.71 | 29255136 | |
| 67 | Phosphorylation | PEERLSPTPSMQDGL CHHHCCCCCCCCCCC | 25.31 | 29255136 | |
| 69 | Phosphorylation | ERLSPTPSMQDGLDL HHCCCCCCCCCCCCC | 31.39 | 29255136 | |
| 164 | Phosphorylation | RQLRGKRTPSPLILD HHHCCCCCCCCEEEC | 31.44 | 28450419 | |
| 166 | Phosphorylation | LRGKRTPSPLILDQN HCCCCCCCCEEECCC | 31.55 | 28464451 | |
| 178 | Ubiquitination | DQNYINTKNQVIKAE CCCCCCCHHHHHHHH | 40.68 | 29967540 | |
| 183 | Acetylation | NTKNQVIKAERRVLK CCHHHHHHHHHHHHH | 45.39 | 25953088 | |
| 289 | Phosphorylation | CIETLRLYTRKKPNY HHHHHHHHCCCCCCH | 9.69 | - | |
| 314 | Acetylation | KVALQEAKLKAKGLN HHHHHHHHHHHCCCC | 50.17 | 25953088 | |
| 325 | Phosphorylation | KGLNPDGTPALSTLG CCCCCCCCCCHHHCC | 16.87 | 29255136 | |
| 329 | Phosphorylation | PDGTPALSTLGGFSP CCCCCCHHHCCCCCC | 24.56 | 29255136 | |
| 330 | Phosphorylation | DGTPALSTLGGFSPA CCCCCHHHCCCCCCC | 30.21 | 29255136 | |
| 335 | Phosphorylation | LSTLGGFSPASKPSS HHHCCCCCCCCCCCC | 23.88 | 29255136 | |
| 338 | Phosphorylation | LGGFSPASKPSSPRE CCCCCCCCCCCCCCC | 48.78 | 29255136 | |
| 339 | Sumoylation | GGFSPASKPSSPREV CCCCCCCCCCCCCCC | 51.53 | 28112733 | |
| 341 | Phosphorylation | FSPASKPSSPREVKA CCCCCCCCCCCCCCC | 57.63 | 22167270 | |
| 342 | Phosphorylation | SPASKPSSPREVKAE CCCCCCCCCCCCCCC | 36.18 | 22167270 | |
| 347 | Sumoylation | PSSPREVKAEEKSPI CCCCCCCCCCCCCCC | 45.38 | 28112733 | |
| 352 | Phosphorylation | EVKAEEKSPISINVK CCCCCCCCCCEEEEE | 30.64 | 29255136 | |
| 355 | Phosphorylation | AEEKSPISINVKTVK CCCCCCCEEEEEEEC | 16.11 | 22167270 | |
| 359 | Acetylation | SPISINVKTVKKEPE CCCEEEEEEECCCHH | 43.01 | 25953088 | |
| 362 | Sumoylation | SINVKTVKKEPEDRQ EEEEEEECCCHHHHH | 57.56 | 25755297 | |
| 372 | Phosphorylation | PEDRQQASKSPYNGV HHHHHHHCCCCCCCC | 29.36 | 23401153 | |
| 374 | Phosphorylation | DRQQASKSPYNGVRK HHHHHCCCCCCCCCC | 30.07 | 23401153 | |
| 376 | Phosphorylation | QQASKSPYNGVRKDS HHHCCCCCCCCCCCC | 31.47 | 30266825 | |
| 401 | Phosphorylation | RSRSRTRSRSRSHTP HHHHHHHHHCCCCCC | 33.71 | 19651622 | |
| 403 | Phosphorylation | RSRTRSRSRSHTPRR HHHHHHHCCCCCCCC | 39.11 | 19651622 | |
| 405 | Phosphorylation | RTRSRSRSHTPRRHY HHHHHCCCCCCCCCC | 32.72 | 19651622 | |
| 407 | Phosphorylation | RSRSRSHTPRRHYNN HHHCCCCCCCCCCCC | 21.53 | 25599653 | |
| 417 | Phosphorylation | RHYNNRRSRSGTYSS CCCCCCCCCCCCCCC | 27.79 | - | |
| 419 | Phosphorylation | YNNRRSRSGTYSSRS CCCCCCCCCCCCCCC | 36.41 | - | |
| 421 | Phosphorylation | NRRSRSGTYSSRSRS CCCCCCCCCCCCCCC | 22.83 | - | |
| 422 | Phosphorylation | RRSRSGTYSSRSRSR CCCCCCCCCCCCCCC | 14.26 | 21406692 | |
| 423 | Phosphorylation | RSRSGTYSSRSRSRS CCCCCCCCCCCCCCC | 21.07 | 21406692 | |
| 424 | Phosphorylation | SRSGTYSSRSRSRSR CCCCCCCCCCCCCCC | 24.70 | 21406692 | |
| 426 | Phosphorylation | SGTYSSRSRSRSRSH CCCCCCCCCCCCCCC | 36.23 | 21406692 | |
| 430 | Phosphorylation | SSRSRSRSRSHSESP CCCCCCCCCCCCCCC | 39.11 | 24719451 | |
| 432 | Phosphorylation | RSRSRSRSHSESPRR CCCCCCCCCCCCCCC | 32.39 | 30177828 | |
| 434 | Phosphorylation | RSRSRSHSESPRRHH CCCCCCCCCCCCCCC | 40.80 | 30177828 | |
| 436 | Phosphorylation | RSRSHSESPRRHHNH CCCCCCCCCCCCCCC | 27.07 | 24719451 | |
| 445 | Phosphorylation | RRHHNHGSPHLKAKH CCCCCCCCCCHHCCC | 11.12 | 27362937 | |
| 449 | Acetylation | NHGSPHLKAKHTRDD CCCCCCHHCCCCHHH | 52.97 | 7427899 | |
| 451 | Acetylation | GSPHLKAKHTRDDLK CCCCHHCCCCHHHHH | 43.87 | 7427909 | |
| 470 | Phosphorylation | HGHKRKKSRSRSQSK HHCCHHHHHCHHHHH | 38.22 | - | |
| 471 | Methylation | GHKRKKSRSRSQSKS HCCHHHHHCHHHHHC | 44.99 | - | |
| 473 | Methylation | KRKKSRSRSQSKSRD CHHHHHCHHHHHCCC | 37.29 | - | |
| 486 | Ubiquitination | RDHSDAAKKHRHERG CCCHHHHHHHHHHHH | 51.32 | - | |
| 487 | Ubiquitination | DHSDAAKKHRHERGH CCHHHHHHHHHHHHC | 40.94 | - | |
| 502 | Phosphorylation | HRDRRERSRSFERSH HHHHHHHHHHHHHHH | 27.76 | 28355574 | |
| 504 | Phosphorylation | DRRERSRSFERSHKS HHHHHHHHHHHHHCC | 32.48 | 28355574 | |
| 512 | Methylation | FERSHKSKHHGGSRS HHHHHCCCCCCCCCC | 44.41 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CCNL1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CCNL1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CCNL1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CD11A_HUMAN | CDK11A | physical | 11980906 | |
| CD11A_HUMAN | CDK11A | physical | 11683997 | |
| A4_HUMAN | APP | physical | 21832049 | |
| JMJD6_HUMAN | JMJD6 | physical | 23455924 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-335; SER-338; SER-352AND SER-355, AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-325; SER-329; SER-335;SER-338; SER-341 AND SER-342, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-325; SER-335; SER-338;SER-342; SER-352 AND SER-355, AND MASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65, AND MASSSPECTROMETRY. | |
| "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-352, AND MASSSPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-352, AND MASSSPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65 AND SER-355, AND MASSSPECTROMETRY. | |